TB drug price slashed in global push to thwart killer disease
A medical supervisor holds a packet of medicine to treat tuberculosis (TB) in the government-run Osmania General Hospital in Hyderabad on October 30, 2019. PHOTO | NOAH SEELAM | AFP
The initiatives comes as the UN seeks to galvanise the campaign against TB, which killed 1.5 million people worldwide last year and saw 10 million more infected.
Aid agencies have become increasingly frustrated at the slow pace of fighting the disease, which the UN hopes to eradicate by 2030.
Only 1.8 million people are on preventive TB therapies, but a UN health summit last year set a target of 30 million people to be on such drugs by 2022.
HYDERABAD,
A pharmaceutical multinational on Thursday slashed the price of a key anti-tuberculosis drug boosting the battle against the world's deadliest infectious disease, as a new treatment was also set to begin extensive testing.
